New research indicates that a novel approach to cancer immunotherapy may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma. Investigators from the Massachusetts General Hospital (MGH) Vaccine and Immunotherapy Center report in the emJournal of Hematology (and) Oncology/em that a protein engineered to combine a molecule targeting a tumor-cell-surface antigen with another protein that stimulates ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/1imgb6T
No comments:
Post a Comment